WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. GOOGL
6. VRTS
7. HPE
8. SPY
9. SNOW
10. USO

Go back to WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications
Merck & Co. (NYSE: MRK) Delayed: 151.64 +1.78 (1.19%)
Previous Close $149.86    52 Week High $65.46 
Open $151.50    52 Week Low $47.97 
Day High $152.69    P/E 103.16 
Day Low $149.97    EPS $1.47 
Volume 8,970,590